Tirzepatide 10mg from Eutropen Laboratories is an injectable medication designed for the management of type 2 diabetes. This active ingredient acts as a dual agonist of GLP-1 and GIP receptors, helping to regulate blood glucose levels and promoting improved insulin sensitivity.
Each unit contains 10mg of high-purity tirzepatide, formulated by Eutropen, a laboratory recognized for its pharmaceutical quality standards. The medication is administered via subcutaneous injection according to medical instructions.
This product is indicated for patients requiring optimized glycemic control as part of their comprehensive treatment plan. Use under professional medical supervision is recommended to ensure appropriate dosing and monitoring of the therapeutic response.